Chiara Riganti

Graduated in Medicine at University of Torino, Italy (2002); post-graduated at the School of Specialization in Clinical Biochemistry, Faculty of Medicine, University of Torino, Italy (2006); since 2009-present: tenured assistant professor of Biochemistry at the Faculty of Medicine, University of Torino, Italy. Visiting scientist at Institut Cochin (Laboratoire de Biologie de l’endothelium cerebrale), Universitè Renè Descartes, Paris (2010) and at Weizmann Institute of Science (Department of Molecular Genetics), Rehovot, Israel (2011 and 2013). Awards: SIB (Italian Society of Biochemistry) Award for young investigators (2005); AICC/ECTS (Italian Association for Cells Culture/Italian Branch of the European Tissue Culture Society) Award (2011): Affiliations: member of SIB, FEBS (Federation of European Biochemistry Society); AICC, ECTS, BSP (British Society of Pharmacology) Research topics: genesis and reversion of multidrug resistance (MDR) and immunoresistance in human cancer cells; correlation between mevalonate pathway activity and immue system activity.